62 related articles for article (PubMed ID: 9070212)
1. Phosphodiesterase inhibitors prevent endothelin-1-induced vasoconstriction, bronchoconstriction, and thromboxane release in perfused rat lung.
Held HD; Wendel A; Uhlig S
Biochem Biophys Res Commun; 1997 Feb; 231(1):22-5. PubMed ID: 9070212
[TBL] [Abstract][Full Text] [Related]
2. Attenuation by phosphodiesterase inhibitors of lipopolysaccharide-induced thromboxane release and bronchoconstriction in rat lungs.
Uhlig S; Featherstone RL; Held HD; Nüsing R; Schudt C; Wendel A
J Pharmacol Exp Ther; 1997 Dec; 283(3):1453-9. PubMed ID: 9400021
[TBL] [Abstract][Full Text] [Related]
3. Comparison of phosphodiesterase III, IV and dual III/IV inhibitors on bronchospasm and pulmonary eosinophil influx in guinea pigs.
Underwood DC; Kotzer CJ; Bochnowicz S; Osborn RR; Luttmann MA; Hay DW; Torphy TJ
J Pharmacol Exp Ther; 1994 Jul; 270(1):250-9. PubMed ID: 8035322
[TBL] [Abstract][Full Text] [Related]
4. Airway relaxant and anti-inflammatory properties of a PDE4 inhibitor with low affinity for the high-affinity rolipram binding site.
Martin C; Göggel R; Dal Piaz V; Vergelli C; Giovannoni P; Ernst M; Uhlig S
Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr; 365(4):284-9. PubMed ID: 11919652
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary antiallergic and bronchodilator effects of isozyme-selective phosphodiesterase inhibitors in guinea pigs.
Howell RE; Sickels BD; Woeppel SL
J Pharmacol Exp Ther; 1993 Feb; 264(2):609-15. PubMed ID: 8437112
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of neurally mediated nonadrenergic, noncholinergic contractions of guinea pig bronchus by isozyme-selective phosphodiesterase inhibitors.
Undem BJ; Meeker SN; Chen J
J Pharmacol Exp Ther; 1994 Nov; 271(2):811-7. PubMed ID: 7965800
[TBL] [Abstract][Full Text] [Related]
7. Subthreshold doses of specific phosphodiesterase type 3 and 4 inhibitors enhance the pulmonary vasodilatory response to nebulized prostacyclin with improvement in gas exchange.
Schermuly RT; Roehl A; Weissmann N; Ghofrani HA; Schudt C; Tenor H; Grimminger F; Seeger W; Walmrath D
J Pharmacol Exp Ther; 2000 Feb; 292(2):512-20. PubMed ID: 10640287
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of the mixed ET(A)/ET(B)-receptor antagonist bosentan on endothelin-induced bronchoconstriction, vasoconstriction and prostacyclin release.
Martin C; Held HD; Uhlig S
Naunyn Schmiedebergs Arch Pharmacol; 2000 Aug; 362(2):128-36. PubMed ID: 10961375
[TBL] [Abstract][Full Text] [Related]
9. Stimulation of the hypothalamo-pituitary-adrenal axis in the rat by three selective type-4 phosphodiesterase inhibitors: in vitro and in vivo studies.
Kumari M; Cover PO; Poyser RH; Buckingham JC
Br J Pharmacol; 1997 Jun; 121(3):459-68. PubMed ID: 9179387
[TBL] [Abstract][Full Text] [Related]
10. In vitro differentiation of human monocytes to macrophages: change of PDE profile and its relationship to suppression of tumour necrosis factor-alpha release by PDE inhibitors.
Gantner F; Kupferschmidt R; Schudt C; Wendel A; Hatzelmann A
Br J Pharmacol; 1997 May; 121(2):221-31. PubMed ID: 9154331
[TBL] [Abstract][Full Text] [Related]
11. The interaction of endothelin receptor responses in the isolated perfused rat lung.
Uhlig S; Featherstone RL
Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):392-7. PubMed ID: 9303578
[TBL] [Abstract][Full Text] [Related]
12. Effects of inhibitors of phosphodiesterase, on antigen-induced bronchial hyperreactivity in conscious sensitized guinea-pigs and airway leukocyte infiltration.
Danahay H; Broadley KJ
Br J Pharmacol; 1997 Jan; 120(2):289-97. PubMed ID: 9117122
[TBL] [Abstract][Full Text] [Related]
13. Differential in vivo and in vitro bronchorelaxant activities of CP-80,633, a selective phosphodiesterase 4 inhibitor.
Wright KF; Turner CR; Jayasinghe-Beck R; Cohen VL; Cheng JB; Watson JW
Can J Physiol Pharmacol; 1997 Aug; 75(8):1001-8. PubMed ID: 9360015
[TBL] [Abstract][Full Text] [Related]
14. A study of mechanisms underlying amitriptyline-induced acute lung function impairment.
Svens K; Ryrfeldt A
Toxicol Appl Pharmacol; 2001 Dec; 177(3):179-87. PubMed ID: 11749117
[TBL] [Abstract][Full Text] [Related]
15. Functional and biochemical evidence for diazepam as a cyclic nucleotide phosphodiesterase type 4 inhibitor.
Collado MC; Beleta J; Martinez E; Miralpeix M; Domènech T; Palacios JM; Hernández J
Br J Pharmacol; 1998 Mar; 123(6):1047-54. PubMed ID: 9559885
[TBL] [Abstract][Full Text] [Related]
16. Intravasal peroxynitrite generation causes dysfunction in the isolated perfused rat lung via endothelin.
Eichert K; Hamacher J; Wunder MA; Wendel A
J Pharmacol Exp Ther; 2001 Apr; 297(1):128-32. PubMed ID: 11259536
[TBL] [Abstract][Full Text] [Related]
17. Modulation of cell adhesion molecule expression and function on human lung microvascular endothelial cells by inhibition of phosphodiesterases 3 and 4.
Blease K; Burke-Gaffney A; Hellewell PG
Br J Pharmacol; 1998 May; 124(1):229-37. PubMed ID: 9630364
[TBL] [Abstract][Full Text] [Related]
18. Selective type IV phosphodiesterase inhibitors prevent IL-4-induced IgE production by human peripheral blood mononuclear cells.
Coqueret O; Boichot E; Lagente V
Clin Exp Allergy; 1997 Jul; 27(7):816-23. PubMed ID: 9249275
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of hydroperoxide-induced broncho- and vasoconstriction in isolated and perfused rat lung.
Olafsdóttir K; Atzori L; Ryrfeldt A; Berggren M; Kumlin M; Moldéus P
Pharmacol Toxicol; 1991 Mar; 68(3):181-6. PubMed ID: 1905406
[TBL] [Abstract][Full Text] [Related]
20. Phosphodiesterase 4 inhibitors modulate beta2-adrenoceptor agonist-induced human airway hyperresponsiveness.
Faisy C; Risse PA; Naline E; Guerot E; Fagon JY; Devillier P; Advenier C
Life Sci; 2006 Oct; 79(20):1929-35. PubMed ID: 16820175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
